The hidden life of NAD+-consuming ectoenzymes in the endocrine system

Journal of Molecular Endocrinology

Volumn 45, Issue 4, 2010, Pages 183-191

  Malavasi, Fabio ^a   Deaglio, Silvia ^a   Zaccarello, Gianluca ^a   Horenstein, Alberto L ^a   Chillemi, Antonella ^a   Audrito, Valentina ^a   Serra, Sara ^a   Gandione, Marina ^a   Zitella, Andrea ^a   Tizzani, Alessandro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD157 ANTIGEN; CD38 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NUCLEOSIDE; NUCLEOTIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SIRTUIN; SIRTUIN 1;

BONE REMODELING; CELL MIGRATION; ENDOCRINE SYSTEM; ENZYME ACTIVITY; HORMONE RECEPTOR INTERACTION; IMMUNOCOMPETENT CELL; INSULIN RELEASE; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; ENDOCRINE SYSTEM; ENZYMES; HUMANS; MODELS, BIOLOGICAL; NAD;

EID: 77957849625     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-10-0082     Document Type: Review

References (56)

1. Abbracchio MP & Burnstock G 1994 Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacology and Therapeutics 64 445-475. (doi:10.1016/0163-7258(94)00048-4)
2. 2+ homeostasis. Nature Cell Biology 1 409-414. (doi:10.1038/15640)
3. Barabasi AL 2007 Networkmedicine - from obesity to the "diseasome". New England Journal of Medicine 357 404-407. (doi:10.1056/NEJMe078114)
4. Barabasi AL & Oltvai ZN 2004 Network biology: understanding the cell's functional organization. Nature Reviews. Genetics 5 101-113. (doi:10.1038/nrg1272)
5. Burnstock G 2008 Purinergic signalling and disorders of the central nervous system. Nature Reviews. Drug Discovery 7 575-590. (doi:10. 1038/nrd2605) (Pubitemid 351927723)
6. Burnstock G 2009 Purinergic signalling: past, present and future. Brazilian Journal of Medical and Biological Research 42 3-8. (doi:10. 1590/S0100-879X2008005000037)
7. Burnstock G & Knight GE 2004 Cellular distribution and functions of P2 receptor subtypes in different systems. International Review of Cytology 240 31-304. (doi:10.1016/S0074-7696(04)40002-3)
8. Burnstock G & Verkhratsky A 2009 Evolutionary origins of the purinergic signalling system. Acta Physiologica 195 415-447. (doi:10. 1111/j.1748-1716.2009.01957.x)
9. Cassoni P, Fulcheri E, Carcangiu ML, Stella A, Deaglio S & Bussolati G 2000 Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance. Journal of Pathology 190 470-477. (doi:10.1002/(SICI)1096- 9896(200003)190:4〈470::AID-PATH550〉3.0.CO;2- G) (Pubitemid 30163588)
10. Chen J, Chen YG, Reifsnyder PC, Schott WH, Lee CH, Osborne M, Scheuplein F, Haag F, Koch-Nolte F, Serreze DV et al. 2006a Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion. Journal of Immunology 176 4590-4599.
11. Chen YG, Chen J, Osborne MA, Chapman HD, Besra GS, Porcelli SA, Leiter EH, Wilson SB & Serreze DV 2006b CD38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T cells in nonobese diabetic mice. Journal of Immunology 177 2939-2947. (Pubitemid 44277809)
12. Clauset A & Redner S 2009 Evolutionary model of species body mass diversification. Physical Review Letters 102 038103. (doi:10.1103/ PhysRevLett.102.038103)
13. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R & Sinclair DA 2004 Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 390-392. (doi:10.1126/science. 1099196)
14. Deaglio S & Malavasi F 2006 The CD38/CD157mammalian gene family: an evolutionary paradigm for other leukocyte surface enzymes. Purinergic Signalling 2 431-441. (doi:10.1007/s11302-006-9002-6)
15. Deaglio S, Capobianco A, Cali A, Bellora F, Alberti F, Righi L, Sapino A, Camaschella C & Malavasi F 2002 Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum. Blood 100 3782-3789. (doi:10.1182/blood- 2002-01-0076) (Pubitemid 35303952)
16. Goding JW & Howard MC 1998 Ecto-enzymes of lymphoid cells. Immunological Reviews 161 5-10. (doi:10.1111/j.1600-065X.1998.tb01567.x)
17. +: a modulator of immune functions. Innate Immunity (In Press). (doi:10.1177/1753425910361989)
18. Haigis MC & Sinclair DA 2010 Mammalian sirtuins: biological insights and disease relevance. Annual Review of Pathology 5 253-295. (doi:10. 1146/annurev.pathol.4.110807.092250)
19. +: an old metabolite controlling new metabolic signaling pathways. Endocrine Reviews 31 194-223. (doi:10.1210/er.2009-0026)
20. Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM, Walseth TF & Lee HC 1993 Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262 1056-1059. (doi:10.1126/science.8235624) (Pubitemid 24035045)
21. Imam A, Iqbal J, Blair HC, Davies TF, Huang CL, Zallone A, Zaidi M & Sun L 2009 Role of the pituitary-bone axis in skeletal pathophysiology. Current Opinion in Endocrinology, Diabetes, and Obesity 16 423-429. (doi:10.1097/MED. 0b013e3283328aee)
22. + metabolism modulates osteoclastogenesis. Biochemical and Biophysical Research Communications 349 533-539. (doi:10.1016/j.bbrc.2006.08.108)
23. Jin D, Liu HX, Hirai H, Torashima T, Nagai T, Lopatina O, Shnayder NA, Yamada K, Noda M, Seike Tet al. 2007 CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446 41-45. (doi:10.1038/nature05526)
24. Johnson JD, Ford EL, Bernal-Mizrachi E, Kusser KL, Luciani DS,Han Z, Tran H, Randall TD, Lund FE & Polonsky KS 2006 Suppressed insulin signaling and increased apoptosis in CD38-null islets. Diabetes 55 2737-2746. (doi:10.2337/db05-1455) (Pubitemid 44923672)
25. Kato I, Takasawa S, Akabane A, Tanaka O, Abe H, Takamura T, Suzuki Y, Nata K, Yonekura H, Yoshimoto T et al. 1995 Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic beta cells. Enhanced insulin secretion in CD38-expressing transgenic mice. Journal of Biological Chemistry 270 30045-30050. (doi:10.1074/jbc.270.50. 30045)
26. i, and insulin secretion. Journal of Biological Chemistry 274 1869-1872. (doi:10.1074/jbc.274.4.1869)
27. Kauppinen TM 2007 Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease. Neurochemistry International 50 954-958. (doi:10.1016/j.neuint.2006.11.010)
28. Kauppinen TM & Swanson RA 2007 The role of poly(ADP-ribose) polymerase-1 in CNS disease. Neuroscience 145 1267-1272. (doi:10. 1016/j.neuroscience.2006.09.034)
29. + into a nuclear signal. Genes and Development 19 1951-1967. (doi:10.1101/gad.1331805)
30. Koch-Nolte F, Kernstock S, Mueller-Dieckmann C, Weiss MS & Haag F 2008 Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases. Frontiers in Bioscience 13 6716-6729. (doi:10.2741/3184)
31. Koshiyama H, Ogawa Y, Tanaka K & Tanaka I 2010 Integrated network systems and evolutionary developmental endocrinology. Medical Hypotheses 74 132-138. (doi:10.1016/j.mehy.2009.07.028)
32. 2+ stores: a perspective from cyclic ADP-ribose and NAADP. Current Molecular Medicine 4 227-237. (doi:10.2174/1566524043360753)
33. Liang F, Kume S & Koya D 2009 SIRT1 and insulin resistance. Nature Reviews. Endocrinology 5 367-373. (doi:10.1038/nrendo.2009.101)
34. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L & Mehta K 1994 Human CD38: a glycoprotein in search of a function. Immunology Today 15 95-97. (doi:10.1016/0167-5699(94)90148-1) (Pubitemid 24076322)
35. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T & Aydin S 2008 Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiological Reviews 88 841-886. (doi:10.1152/physrev.00035.2007)
36. Michan S & Sinclair D 2007 Sirtuins in mammals: insights into their biological function. Biochemical Journal 404 1-13. (doi:10.1042/BJ20070140) (Pubitemid 46788079)
37. + is an agonist of the human P2Y11 purinergic receptor in human granulocytes. Journal of Biological Chemistry 281 31419-31429. (doi:10.1074/jbc.M606625200)
38. Munesue T, Yokoyama S, Nakamura K, Anitha A, Yamada K, Hayashi K, Asaka T, Liu HX, Jin D, Koizumi K et al. 2010 Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neuroscience Research 67 181-191. (doi:10.1016/j.neures.2010.03.004)
39. North RA 2002 Molecular physiology of P2X receptors. Physiological Reviews 82 1013-1067. (doi:10.1152/physrev.00015.2002)
40. Okamoto H & Takasawa S 2002 Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes 51 (Suppl 3) S462-S473. (doi:10.2337/diabetes.51.2007.S462)
41. Pallas M, Verdaguer E, Tajes M, Gutierrez-Cuesta J & Camins A 2008 Modulation of sirtuins: new targets for antiageing. Recent Patents on CNS Drug Discovery 3 61-69. (doi:10.2174/157488908783421492) (Pubitemid 351223186)
42. Peralta-Leal A, Rodriguez-Vargas JM, Aguilar-Quesada R, Rodriguez MI, Linares JL, de Almodovar MR & Oliver FJ 2009 PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Free Radical Biology and Medicine 47 13-26. (doi:10.1016/j.freeradbiomed.2009.04.008)
43. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R et al. 2001 ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411 595-599. (doi:10.1038/ 35079100)
44. Petit P, Lajoix AD & Gross R 2009 P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology. European Journal of Pharmaceutical Sciences 37 67-75. (doi:10.1016/ j.ejps.2009.01.007)
45. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH & Poirier GG 2010 PARP inhibition: PARP1 and beyond. Nature Reviews. Cancer 10 293-301. (doi:10.1038/nrc2812)
46. Salmi M & Jalkanen S 2005 Cell-surface enzymes in control of leukocyte trafficking. Nature Reviews. Immunology 5 760-771. (doi:10.1038/nri1705) (Pubitemid 41400850)
47. Salmina AB, Lopatina O, Ekimova MV, Mikhutkina SV & Higashida H 2010 CD38/cADPR-system: a new player for oxytocin secretion and regulation of social behaviour. Journal of Neuroendocrinology 22 380-392. (doi:10.1111/j.1365-2826. 2010.01970.x)
48. Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G, Deterre P, Haag F & Koch-Nolte F 2003 NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19 571-582. (doi:10.1016/ S1074-7613(03)00266-8) (Pubitemid 37311438)
49. States DJ, Walseth TF & Lee HC 1992 Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38. Trends in Biochemical Science 17 495. (doi:10.1016/ 0968-0004(92)90337-9)
50. Stojilkovic SS 2009 Purinergic regulation of hypothalamopituitary functions. Trends in Endocrinology and Metabolism 20 460-468. (doi:10.1016/j.tem.2009.05.005)
51. Sun L, Adebanjo OA, Moonga BS, Corisdeo S, Anandatheerthavarada HK, Biswas G, Arakawa T, Hakeda Y, Koval A, Sodam B et al. 1999 CD38/ADP-ribosyl cyclase: a new role in the regulation of osteoclastic bone resorption. Journal of Cell Biology 146 1161-1172. (doi:10.1083/jcb.146.5.1161)
52. Sun L, Iqbal J, Dolgilevich S, Yuen T, Wu XB, Moonga BS, Adebanjo OA, Bevis PJ, Lund F, Huang CL et al. 2003 Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB Journal 17 369-375. (doi:10. 1096/fj.02-0205com) (Pubitemid 36292952)
53. Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L et al. 2009 Oxytocin is an anabolic bone hormone. PNAS 106 7149-7154. (doi:10.1073/pnas.0901890106)
54. Trautmann A 2009 Extracellular ATP in the immune system: more than just a "danger signal". Science Signaling 2 pe6. (doi:10.1126/scisignal. 256pe6)
55. Zingg HH & Laporte SA 2003 The oxytocin receptor. Trends in Endocrinology and Metabolism 14 222-227. (doi:10.1016/S1043- 2760(03)00080-8)
56. Zumaquero E, Munoz P, Cobo M, Lucena G, Pavon EJ, Martin A, Navarro P, Garcia-Perez A, Ariza-Veguillas A, Malavasi F et al. 2010 Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and lyn. Experimental Cell Research. (doi:10. 1016/j.yexcr.2010.05.032)